Exhibit 99.1

LOGO

FOR IMMEDIATE RELEASE

 

Contacts:    Urologix:
   Stryker Warren, Jr., CEO
   (763) 475-1400

UROLOGIX REPORTS FISCAL 2009 RESULTS INCLUDING SEQUENTIAL

GROWTH IN FOURTH QUARTER FISCAL YEAR 2009 REVENUE

 

 

Increased Revenue by 4% Compared to Third Quarter Fiscal 2009

 

 

Reduced Net Loss by 27% Compared to Third Quarter Fiscal 2009

 

 

Reduced Operating Expenses by 5% Compared to Third Quarter Fiscal 2009

MINNEAPOLIS — August 25, 2009 — Urologix®, Inc. (NASDAQ:ULGX), a medical device company focused on developing, manufacturing and marketing Cooled ThermoTherapy™ systems, a durable and effective catheter based in-office alternative to drugs or surgery for patients suffering from benign prostatic hyperplasia (BPH), today reported financial results for the fourth quarter ended June 30, 2009 and for fiscal year 2009.

2009 Fourth Quarter Financial Results

Revenue for the fourth quarter was $3.4 million, or 4 percent more than the $3.3 million reported in the third quarter of this fiscal year; however, it was 6 percent less than the $3.7 million reported in the same period of fiscal 2008.

Net loss for the fourth quarter was $876,000, or a loss of $0.06 per diluted share. This compares to a net loss of $1.2 million or $0.08 per diluted share in the third quarter of fiscal 2009, and a loss of $2.2 million or $0.16 per diluted share for the fourth quarter of fiscal 2008.

Cash utilization for the quarter ended June 30, 2009 was $603,000, a 33 percent reduction from the cash utilization of the prior fiscal quarter and an 11 percent reduction from the cash utilization in the fourth quarter of fiscal 2008. The Company’s cash balance was $7.0 million as of June 30, 2009, which management considers sufficient to fund working capital and capital resource needs beyond fiscal year 2010.

“We believe the fourth quarter results continue to demonstrate the early returns from a stable and maturing sales force, improved operational efficiencies and management of departmental expenses. In the fourth quarter of fiscal year 2009, we left the American Urological Association (AUA) 2009 Annual Meeting having introduced the complete CTC Advance® catheter family, robust five year data dramatizing durable clinical outcomes, and the first data supporting the ability to customize our high energy, Cooled ThermoTherapy treatment for patient


The following information was filed by Urologix Inc (ULGX) on Thursday, August 27, 2009 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Urologix Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Urologix Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account